Bailard’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $960K | Buy |
13,909
+941
| +7% | +$64.9K | 0.02% | 333 |
|
|
2025
Q1 | $900K | Buy |
12,968
+4,282
| +49% | +$297K | 0.02% | 327 |
|
|
2024
Q4 | $747K | Sell |
8,686
-3,662
| -30% | -$315K | 0.02% | 356 |
|
|
2024
Q3 | $1.47M | Buy |
12,348
+845
| +7% | +$101K | 0.04% | 258 |
|
|
2024
Q2 | $1.64M | Sell |
11,503
-892
| -7% | -$127K | 0.05% | 246 |
|
|
2024
Q1 | $1.59M | Buy |
12,395
+4,567
| +58% | +$586K | 0.04% | 249 |
|
|
2023
Q4 | $810K | Sell |
7,828
-363
| -4% | -$37.6K | 0.02% | 324 |
|
|
2023
Q3 | $745K | Buy |
8,191
+187
| +2% | +$17K | 0.02% | 321 |
|
|
2023
Q2 | $648K | Buy |
8,004
+842
| +12% | +$68.1K | 0.02% | 335 |
|
|
2023
Q1 | $570K | Buy |
7,162
+60
| +0.8% | +$4.77K | 0.02% | 366 |
|
|
2022
Q4 | $481K | Sell |
7,102
-834
| -11% | -$56.4K | 0.02% | 409 |
|
|
2022
Q3 | $395K | Buy |
7,936
+322
| +4% | +$16K | 0.02% | 409 |
|
|
2022
Q2 | $424K | Sell |
7,614
-824
| -10% | -$45.9K | 0.02% | 405 |
|
|
2022
Q1 | $469K | Buy |
8,438
+1,496
| +22% | +$83.2K | 0.02% | 418 |
|
|
2021
Q4 | $389K | Buy |
+6,942
| New | +$389K | 0.01% | 455 |
|